$ 0 $ 9 $ 1 Adjustments to reconcile net income to net cash from operations:
Depreciation, amortization, and other noncash items 2,673 2,562 2,056
Stock-based compensation 1,891 1,708 1,479 Net recognized losses (gains) on investments and derivatives (208) 683 (572) Excess tax benefits from stock-based compensation (45) (52) (120) Deferred income taxes (220) 762 935 Deferral of unearned revenue 29,374 24,409 24,532 Recognition of unearned revenue (28,813) (25,426) (21,944) Changes in operating assets and liabilities:
Accounts receivable (2,238) 2,215 (1,569)
Other current assets 420 (422) 153 Other long-term assets (223) (273) (98) Other current liabilities 1,295 (3,371) (748) Other long-term liabilities 1,407 1,673 (173)
Net cash from operations 24,073 19,037 21,612
Financing
Short-term borrowings (repayments), maturities of 90 days or
less, net (991) 1,178 0 Proceeds from issuance of debt, maturities longer than 90 days 4,167 4,796 0 Repayments of debt, maturities longer than 90 days (2,986) (228) 0 Common stock issued 2,311 579 3,494 Common stock repurchased (11,269) (9,353) (12,533) Common stock cash dividends paid (4,578) (4,468) (4,015) Excess tax benefits from stock-based compensation 45 52 120 Other 10 (19) 0
Net cash used in financing (13,291) (7,463) (12,934)
Investing
Additions to property and equipment (1,977) (3,119) (3,182)
Acquisition of companies, net of cash acquired (245) (868) (8,053) Purchases of investments (30,168) (36,850) (20,954) Maturities of investments 7,453 6,191 2,597 Sales of investments 15,125 19,806 25,132 Securities lending payable (1,502) (930) (127)
Net cash used in investing (11,314) (15,770) (4,587)
Effect of exchange rates on cash and cash equivalents (39) (67) 137
Net change in cash and cash equivalents (571) (4,263) 4,228 Cash and cash equivalents, beginning of period 6,076 10,339 6,111
Cash and cash equivalents, end of period $ 5,505 $ 6,076 $ 10,339